What are the indications for the use of beta-blockers in non-CKD patients?
A consensus report based on evidence reviewed by the Pharmaceutical Subcommittee of the Oregon Health Resources Commission in 2008 gave an update of the indications for use of beta-blockers in non-CKD patients. They concluded that although no particular beta-blocker had been shown to be more effective in reducing BP or alleviating angina than another, in cases of mild-to-moderate heart failure, biso- prolol, carvedilol, and metoprolol succinate reduced mortality and in cases of severe heart failure, carvedilol and metoprolol succinate reduced mortality. After a recent myocardial infarction, acebutolol, carvedilol, metoprolol tartrate, propranolol and timolol all reduced mortality.